St. Jude: Device tax a factor in layoffs; Roche gets FDA clearance for herpes tests;

 @FierceMedDev: Watch out, Medtronic, BSX and the rest, researchers have developed a pacemaker that fits on the head of a pin. Story | Follow @FierceMedDev

 @MarkHFierce: So, non-invasive Dx imaging costs for Medicare Part B actually went down from 2006-10. Not so pricey after all. Release | Follow @MarkHFierce

 @DamianFierce: Philips Healthcare's Respironics is conducting its second ventilator recall in as many months. Story | Follow @DamianFierce

> St. Jude Medical ($STJ) confirmed something late last week that analysts had widely concluded: That the looming 2.3% medical device industry tax is "one of many factors" involved in the company's plans to lay off 300 employees. Story

> Roche Diagnostics ($RHHBY) got FDA clearance for two assays that detect herpes simplex virus types 1 and 2 using the company's Cobas platform. Item

> The state government in New South Wales in Australia is launching a major new fund designed to spur development of novel medical devices and related technology. Story

> Saudi regulators say they've destroyed substantial volumes of medical equipment that had become ineffective after being stored in hot and humid places. Story

> Bringing an end to an intellectual property squabble, the University of Pennsylvania and Agios Pharmaceuticals have made peace, with Agios announcing a licensing pact with UPenn that covers IP on diagnostic products that can be used to detect the metabolism of certain cancers. News

> Critical Diagnostics is touting study data showing that its ST2 biomarker can predict heart failure and other adverse events in people who are not medically perceived to be at risk. Release

> OptiMedica has secured 510(k) clearance for Catalys, a laser system designed to create single-plane and multi-plane arc incisions in the cornea during cataract surgery. More

Biotech News

 @FierceBiotech: Penn grabs Agios deal, settling high-profile IP theft claim. Report | Follow @FierceBiotech

 @JohnCFierce: Offbeat: Pulmatrix's Robert Connelly leaves to helm WikiCell, creating "delicious" food packaging; The startup has Flagship, Polaris backing. Release | Follow @JohnCFierce

> Merck KGaA adds big job cuts, $316M R&D makeover to restructuring plan. More

> Valeant scoops up Medicis' dermatology portfolio in $2.6B buyout. News

> Medivation wins groundbreaking FDA OK for blockbuster prostate cancer drug. Article

Pharma News

 @FiercePharma: Here's more on the 'gutter oil' scandal in China, allegedly used to make antibiotics. Report | Follow @FiercePharma

> J&J's Zytiga gets early challenge from Medivation's new pill. Article

> Merck KGaA lines up 1,100 German jobs for the ax. Story

> Valeant puts $2.6B more skin in the dermatology game with Medicis buy. More

Pharma Manufacturing News

> 2 Merck KGaA production facilities whacked in cuts. Article

> Dangers aside, drugmakers can't live without Chinese APIs. Story

Biotech IT News

> Merck Serono bioinformatics head starts new company. Item

> PerkinElmer partners with MGH on informatics system for cancer research. Article

> Video game players take on deadly sepsis for U.S. military. Story

> CLC bio buys molecular docking software company Molegro. News

> Tech startup waltzes with wireless giant in Africa to expand mobile anti-drug counterfeiting system. More

Biotech Research News

> Worm stem cells carry tissue regeneration clues. Report

> Johns Hopkins scientists produce protein that helps track tumors. Item

> Roche/Genentech drug beats back treatment-resistant breast cancer cells. Article

> Cleveland Clinic's Alzheimer's drug makes strong preclinical debut. More

> Gene therapy rebuilds sense of smell in mice. Story

CRO News

> U.K.'s NHS considers commercial services; Big Pharma intrigued. Report

> Hospira drops $200M on Indian API plant. News

> Indian regulator wants to expand its ranks. More

> Charles River snaps up Accugenix for $17M. Story